ASX - By Stock
|
RCE |
Re:
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
|
|
Bpharma
|
54 |
19K |
1 |
16/10/24 |
16/10/24 |
ASX - By Stock
|
54
|
19K
|
1
|
|
ASX - By Stock
|
PVE |
Re:
Ann: Change in substantial holding
|
|
Bpharma
|
5 |
1.9K |
1 |
15/10/24 |
15/10/24 |
ASX - By Stock
|
5
|
1.9K
|
1
|
|
ASX - By Stock
|
LMG |
Re:
general discussion
|
|
Bpharma
|
2.4K |
1.1M |
0 |
15/10/24 |
15/10/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
|
|
Bpharma
|
54 |
19K |
2 |
15/10/24 |
15/10/24 |
ASX - By Stock
|
54
|
19K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
|
|
Bpharma
|
54 |
19K |
1 |
15/10/24 |
15/10/24 |
ASX - By Stock
|
54
|
19K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
|
|
Bpharma
|
54 |
19K |
1 |
15/10/24 |
15/10/24 |
ASX - By Stock
|
54
|
19K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
|
|
Bpharma
|
54 |
19K |
3 |
15/10/24 |
15/10/24 |
ASX - By Stock
|
54
|
19K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
|
|
Bpharma
|
54 |
19K |
3 |
14/10/24 |
14/10/24 |
ASX - By Stock
|
54
|
19K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
|
|
Bpharma
|
54 |
19K |
0 |
14/10/24 |
14/10/24 |
ASX - By Stock
|
54
|
19K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
|
|
Bpharma
|
54 |
19K |
3 |
14/10/24 |
14/10/24 |
ASX - By Stock
|
54
|
19K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
|
|
Bpharma
|
54 |
19K |
4 |
11/10/24 |
11/10/24 |
ASX - By Stock
|
54
|
19K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
|
|
Bpharma
|
54 |
19K |
7 |
11/10/24 |
11/10/24 |
ASX - By Stock
|
54
|
19K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
|
|
Bpharma
|
54 |
19K |
11 |
10/10/24 |
10/10/24 |
ASX - By Stock
|
54
|
19K
|
11
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
|
|
Bpharma
|
54 |
19K |
10 |
09/10/24 |
09/10/24 |
ASX - By Stock
|
54
|
19K
|
10
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
|
|
Bpharma
|
54 |
19K |
8 |
09/10/24 |
09/10/24 |
ASX - By Stock
|
54
|
19K
|
8
|
|
ASX - By Stock
|
PVE |
Re:
Ann: PVE Half Year Financial Report 30 June 2024
|
|
Bpharma
|
17 |
5.0K |
0 |
08/10/24 |
08/10/24 |
ASX - By Stock
|
17
|
5.0K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Establishes Strategic Partnership In South-East Asia
|
|
Bpharma
|
30 |
9.4K |
3 |
04/10/24 |
04/10/24 |
ASX - By Stock
|
30
|
9.4K
|
3
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Bpharma
|
2.1K |
652K |
6 |
04/10/24 |
04/10/24 |
ASX - By Stock
|
2.1K
|
652K
|
6
|
|
ASX - By Stock
|
PVE |
Re:
Ann: PVE Half Year Financial Report 30 June 2024
|
|
Bpharma
|
17 |
5.0K |
2 |
03/10/24 |
03/10/24 |
ASX - By Stock
|
17
|
5.0K
|
2
|
|
ASX - By Stock
|
LMG |
Re:
general discussion
|
|
Bpharma
|
2.4K |
1.1M |
2 |
02/10/24 |
02/10/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
2
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Bpharma
|
2.1K |
652K |
1 |
02/10/24 |
02/10/24 |
ASX - By Stock
|
2.1K
|
652K
|
1
|
|
ASX - By Stock
|
KTA |
Re:
Ann: Mt Clere Nb-REE Gravity Target Continues to Emerge
|
|
Bpharma
|
16 |
16K |
0 |
01/10/24 |
01/10/24 |
ASX - By Stock
|
16
|
16K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Establishes Strategic Partnership In South-East Asia
|
|
Bpharma
|
30 |
9.4K |
4 |
30/09/24 |
30/09/24 |
ASX - By Stock
|
30
|
9.4K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Establishes Strategic Partnership In South-East Asia
|
|
Bpharma
|
30 |
9.4K |
2 |
27/09/24 |
27/09/24 |
ASX - By Stock
|
30
|
9.4K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Establishes Strategic Partnership In South-East Asia
|
|
Bpharma
|
30 |
9.4K |
11 |
26/09/24 |
26/09/24 |
ASX - By Stock
|
30
|
9.4K
|
11
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Establishes Strategic Partnership In South-East Asia
|
|
Bpharma
|
30 |
9.4K |
7 |
26/09/24 |
26/09/24 |
ASX - By Stock
|
30
|
9.4K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Establishes Strategic Partnership In South-East Asia
|
|
Bpharma
|
30 |
9.4K |
9 |
26/09/24 |
26/09/24 |
ASX - By Stock
|
30
|
9.4K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR RECEIVES POSITIVE RESPONSE FROM US FDA FOR PHASE 3
|
|
Bpharma
|
487 |
139K |
1 |
25/09/24 |
25/09/24 |
ASX - By Stock
|
487
|
139K
|
1
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Galactica - Pegasus OGDP I Update
|
|
Bpharma
|
16 |
6.9K |
5 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
16
|
6.9K
|
5
|
|
ASX - By Stock
|
5EA |
Re:
5EA set to skyrocket
|
|
Bpharma
|
1.9K |
970K |
0 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
1.9K
|
970K
|
0
|
|
ASX - By Stock
|
LMG |
Re:
general discussion
|
|
Bpharma
|
2.4K |
1.1M |
0 |
19/09/24 |
19/09/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
0
|
|
ASX - By Stock
|
LMG |
Re:
general discussion
|
|
Bpharma
|
2.4K |
1.1M |
0 |
19/09/24 |
19/09/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
0
|
|
ASX - By Stock
|
PVE |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Bpharma
|
15 |
7.4K |
4 |
11/09/24 |
11/09/24 |
ASX - By Stock
|
15
|
7.4K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Annual Report to Shareholders
|
|
Bpharma
|
12 |
7.8K |
32 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
12
|
7.8K
|
32
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Trading Halt
|
|
Bpharma
|
12 |
5.0K |
5 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
12
|
5.0K
|
5
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Trading Halt
|
|
Bpharma
|
12 |
5.0K |
3 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
12
|
5.0K
|
3
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Helium One Farms into Galactica / Pegasus Project
|
|
Bpharma
|
12 |
5.4K |
2 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
12
|
5.4K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Application for quotation of securities - RCE
|
|
Bpharma
|
12 |
6.4K |
1 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
12
|
6.4K
|
1
|
|
ASX - By Stock
|
LMG |
Re:
general discussion
|
|
Bpharma
|
2.4K |
1.1M |
1 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
1
|
|
ASX - By Stock
|
LMG |
Re:
Ann: July Company Update
|
|
Bpharma
|
22 |
11K |
0 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
22
|
11K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Application for quotation of securities - RCE
|
|
Bpharma
|
12 |
6.4K |
2 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
12
|
6.4K
|
2
|
|
ASX - By Stock
|
BNL |
Re:
chart
|
|
Bpharma
|
25 |
10K |
0 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
25
|
10K
|
0
|
|
ASX - By Stock
|
BNL |
Re:
chart
|
|
Bpharma
|
25 |
10K |
4 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
25
|
10K
|
4
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Significant Helium Discovery at State 16 Well
|
|
Bpharma
|
191 |
64K |
8 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
191
|
64K
|
8
|
|
ASX - By Stock
|
RCE |
Re:
Ann: US Department of Defense Grants US $2m for R327G
|
|
Bpharma
|
10 |
6.2K |
10 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
10
|
6.2K
|
10
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Significant Helium Discovery at State 16 Well
|
|
Bpharma
|
191 |
64K |
2 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
191
|
64K
|
2
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Significant Helium Discovery at State 16 Well
|
|
Bpharma
|
191 |
64K |
3 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
191
|
64K
|
3
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Significant Helium Discovery at State 16 Well
|
|
Bpharma
|
191 |
64K |
2 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
191
|
64K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B
|
|
Bpharma
|
22 |
9.8K |
1 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
22
|
9.8K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B
|
|
Bpharma
|
22 |
9.8K |
5 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
22
|
9.8K
|
5
|
|